Product Information

CEVIMELINE HCL 30 MG CAPSULE is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $0.7080 per EA under NDC 00713093701. Its NADAC has been published 169 times since May 31, 2023.

FDA first approved this application on Jan 11, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the cevimeline hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for CEVIMELINE HCL 30 MG CAPSULE has been published 169 times since May 31, 2023, and over the history we have for it it has declined 42.7%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.